Leticia Cano identified a native citrullinated autoantigen for rheumatoid arthritis for her Ph.D. dissertation. She did her postdoctoral training in the laboratory of Hank Fales at the National Institutes of Health, where she identified candidate biomarkers for Dermatomyositis, Juvenile Idiopathic Arthritis Systemic Lupus Erythematosis. As Founder and President of Biomarker Profiles Corporation, she is interested in developing methods to increase the speed of biomarker discovery.

she is interested in developing methods to increase the speed of biomarker discovery.

Pavel Vodicka graduated at the Medical Faculty, Charles University, Prague and in 1986 obtained Ph.D. in biochemistry. He worked as postdoctoral fellow at the Finnish Institute of Occupational Health, Helsinki, Finland (1987-1990) and as visiting scientist at Karolinska Institute, Huddinge, Sweden (1990-1993). Since 2002 he heads the Dept Molec. Biol. Cancer, Inst. Exper. Medicine, Acad. Sci., Prague, Czech Republic. He has published more than 100 (2430 citations, HI 30) articles. Since 2004, his main research topics are focused on the DNA and chromosomal damage and DNA repair functional tests in humans and on transient biomarkers in the onset of gastrointestinal cancers.

His main research topics are focused on the DNA and chromosomal damage and DNA repair functional tests in humans and on transient biomarkers in the onset of gastrointestinal cancers.

Gabriella Baio studied Medicine and Surgery at University of Pisa and she obtained Radiology specialization at University of Genoa in 2007. Since 2008, she works as Radiologist at IRCCS Azienda Ospedaliera Universitaria San Martino-IST-National Cancer Institute, in Genoa. Dott. Baio research activities, cover clinical and preclinical molecular imaging by Magnetic Resonance and Optical Imaging applied to oncology, vascular and neuroscience. Her current research consist in the characterization of breast cancer in animal model, in order to validate new contrast agents as potential biomarkers for early diagnosis and drug delivery. She is invited speaker to national and international conferences and an active member of the European Society of Molecular Imaging (ESMI). She has been Abstract Reviewer for the World Molecular Imaging Congress (WMIC) 2011 and 2012.

she works as Radiologist at IRCCS Azienda Ospedaliera Universitaria San Martino-IST-National Cancer Institute, in Genoa. Dott. Baio research activities, cover clinical and preclinical molecular imaging by Magnetic Resonance and Optical Imaging applied to oncology, vascular and neuroscience. Her current research consist in the characterization of breast cancer in animal model, in order to validate new contrast agents as potential biomarkers for early diagnosis and drug delivery. She is invited speaker to national and international conferences and an active member of the European Society of Molecular Imaging (ESMI). She has been Abstract Reviewer for the World Molecular Imaging Congress (WMIC) 2011 and 2012.

Professor Marija Krstic-Demonacos has completed her Ph.D. from University of California San Francisco, postdoctoral studies from Glasgow University and was a Lecturer and Principal Investigator in the University of Manchester. She was a recipient of a prestigious Wellcome Trust fellowship and was recently awarded the Honorary Visitor status in the University of Manchester and a Chair in Molecular Medicine in the University of Salford. She has published 43 papers in reputed journals and is serving as an editorial board member of several journals. In addition, commercialization potential of her research is evidenced by the three patents she owns. She was invited to present, chair and organize numerous conferences and has served as reviewer for various funding bodies and journals.

In particular my research group investigates effects of p53, nuclear hormone receptors and histone acetyltransferases on cell proliferation, survival, stress response, brain function and childhood cancer. Our studies aim to analyse the transcription factor activity in stem cells and leukaemia. Our target is to improve treatments and develop novel pharmacologically beneficial approaches to treat cancer.This knowledge can find application in the pharmaceutical industry and medicine.

Afaf El-Ansary, female, biochemist, graduated from biochemistry department, Ain Shams University, Egypt in 1974. She worked in the National Reserch Centre, Egypt from 1976-2000, since 2001, she is working in biochemistry department, King Saud University, KSA. She has published more than 45 papers related to metabolic integration between schistosome parasite and molluscan hosts. She recorded a patent on the “Use of sublethal concentration of solanum nigrum plant for the control of schistosomiasis". She was recognized by the Marquis Who's Who in science and engineering, Eight's edition, 2005-2006. She is member in number of national and international societies and she is recorded as reviewer in many international journals. In recent year she focused on the screening of biochemical markers related to autism and she got another 40 published papers in high impact factor Journals related to this research interest. She is member in Predictive, Preventive and Personalized Medicine Society (Moscow).

She worked in the National Reserch Centre, Egypt from 1976-2000, since 2001, she is working in biochemistry department, King Saud University, KSA. She has published more than 45 papers related to metabolic integration between schistosome parasite and molluscan hosts. She recorded a patent on the “Use of sublethal concentration of solanum nigrum plant for the control of schistosomiasis". She was recognized by the Marquis Who's Who in science and engineering, Eight's edition, 2005-2006. She is member in number of national and international societies and she is recorded as reviewer in many international journals. In recent year she focused on the screening of biochemical markers related to autism and she got another 40 published papers in high impact factor Journals related to this research interest. She is member in Predictive, Preventive and Personalized Medicine Society (Moscow).